228 related articles for article (PubMed ID: 10418722)
1. Immunolocalization of androgen receptor in canine prostatic hyperplasia--effect of antiandrogen.
Murakoshi M; Ikeda R; Tagawa M; Nakayama T; Honma S; Mieda M
Tokai J Exp Clin Med; 1998 Nov; 23(5):209-12. PubMed ID: 10418722
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical studies in canine prostatic hyperplasia--effect of antiandrogen.
Murakoshi M; Ikeda R; Tagawa M; Nakayama T
Tokai J Exp Clin Med; 1999 Jun; 24(2):77-83. PubMed ID: 10641996
[TBL] [Abstract][Full Text] [Related]
3. Effect of antiandrogen, chlormadinone acetate (CMA), in canine spontaneous benign prostatic hyperplasia (BPH).
Murakoshi M; Ikada R; Tagawa M; Nakayama T
Tokai J Exp Clin Med; 2000 Apr; 25(1):11-4. PubMed ID: 11023050
[TBL] [Abstract][Full Text] [Related]
4. Relationship between prostatic atrophy and apoptosis in the canine spontaneous benign prostatic hyperplasia (BPH) following chlormadinone acetate (CMA).
Murakoshi M; Ikeda R; Fukui N; Nakayama T
Tokai J Exp Clin Med; 2001 Jul; 26(2):71-5. PubMed ID: 11806444
[TBL] [Abstract][Full Text] [Related]
5. Atrophic effects of antiandrogen, chlormadinone acetate (CMA) on dog prostate with spontaneous benign prostatic hyperplasia.
Murakoshi M; Tagawa M; Ikeda R
J Toxicol Sci; 2000 Aug; 25(3):143-50. PubMed ID: 10987120
[TBL] [Abstract][Full Text] [Related]
6. The effects of chlormadinone acetate (CMA), antiandrogen, on the pituitary, testis, prostate and adrenal gland of the dog with spontaneous benign prostatic hyperplasia.
Murakoshi M; Ikeda R; Fukui N
J Toxicol Sci; 2001 Aug; 26(3):119-27. PubMed ID: 11552295
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural study in canine prostatic hyperplasia--effect of antiandrogen.
Murakoshi M; Masuda S; Ikeda R; Tagawa M; Nakayama T; Honma S; Mieda M
Tokai J Exp Clin Med; 1998 Nov; 23(5):245-8. PubMed ID: 10418729
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of chlormadinone acetate-pellet implantation and orchidectomy on benign prostatic hypertrophy in the dog.
Kawakami E; Tsutsui T; Shimizu M; Orima H; Fujita M; Ogasa A
Int J Androl; 1995 Oct; 18(5):248-55. PubMed ID: 8567095
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of steroid-induced prostatic hyperplasia in rats by treatment with anti-androgen (TZP-4238).
Murakoshi M; Tagawa M; Inada R; Suzuki M; Mizokami A; Watanabe K
Endocr J; 1993 Aug; 40(4):479-88. PubMed ID: 7522800
[TBL] [Abstract][Full Text] [Related]
10. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
[TBL] [Abstract][Full Text] [Related]
11. Effects of the new steroidal antiandrogen TZP-4238 on hormone-induced canine prostatic hyperplasia.
Takezawa Y; Fukabori Y; Yamanaka H; Mieda M; Honma S; Kushitani M; Hamataki N
Prostate; 1992; 21(4):315-29. PubMed ID: 1281324
[TBL] [Abstract][Full Text] [Related]
12. Effect of anti-androgen (TZP-4238) on steroid-induced canine prostatic hyperplasia. Light and electron microscopic investigations.
Murakoshi M; Inada R; Makino M; Suzuki M; Mieda M; Honma S; Yamanaka H
Acta Pathol Jpn; 1990 Dec; 40(12):871-9. PubMed ID: 1710865
[TBL] [Abstract][Full Text] [Related]
13. Effects of a new steroidal antiandrogen, TZP-4238 (17 alpha-acetoxy-6-chloro-2-oxa-4, 6-pregnadiene-3, 20-dione), on spontaneously developed canine benign prostatic hyperplasia.
Takezawa Y; Ito K; Suzuki K; Fukabori Y; Yamanaka H; Honma S; Mieda M; Hamataki N; Kushitani M
Prostate; 1995 Dec; 27(6):321-8. PubMed ID: 7501544
[TBL] [Abstract][Full Text] [Related]
14. Androgen and prostatic stroma.
Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
[TBL] [Abstract][Full Text] [Related]
15. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
Trachtenberg J; Hicks LL; Walsh PC
J Clin Invest; 1980 May; 65(5):1051-9. PubMed ID: 6154062
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor in the Mongolian gerbil ventral prostate: evaluation during different phases of postnatal development and following androgen blockage.
Cordeiro RS; Scarano WR; Campos SG; Santos FC; Vilamaior PS; Góes RM; Taboga SR
Micron; 2008 Dec; 39(8):1312-24. PubMed ID: 18394909
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory influence of a new steroidal anti-androgen, TZP-4238, on prostatic hyperplasia in the beagle dog.
Murakoshi M; Inada R; Tagawa M; Makino M; Suzuki M; Mieda M; Honma S; Takezawa Y; Yamanaka H
Acta Pathol Jpn; 1992 Mar; 42(3):151-7. PubMed ID: 1373927
[TBL] [Abstract][Full Text] [Related]
18. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
19. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
20. Immunolocalization of androgen receptors, estrogen alpha receptors, and estrogen beta receptors in experimentally induced canine prostatic hyperplasia.
Gallardo F; Lloreta J; García F; Moll X; Baró T; González LA; Morote J; Reventos J; Mogas T
J Androl; 2009; 30(3):240-7. PubMed ID: 19136389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
